Biomedical Sciences Research Institute, University of Ulster, Coleraine, Northern Ireland, UK.
Avellino Lab USA, Inc., Menlo Park, CA, USA.
Eye (Lond). 2018 Jan;32(1):39-43. doi: 10.1038/eye.2017.265. Epub 2017 Dec 1.
PurposeThe post-LASIK exacerbation of corneal dystrophy, otherwise asymptomatic, is almost exclusively associated with the TGFBI gene mutations at codon 124 in exon 4 and codon 555 in exon 12. It is our intention to demonstrate that the pre-operative genetic screening for TGFBI mutations should be mandatory for refractive surgery candidates.Patients and MethodsIn this study, we reviewed the proband's post-LASIK slit-lamp and in vivo confocal microscopy images and genetic testing results, and performed genetic testing on eleven additional members of the family to investigate the penetrance of corneal dystrophy in asymptomatic members who carry the mutation.ResultsThe proband demonstrated a post-LASIK exacerbation of Granular Corneal Dystrophy type 2 (GCD2), identified as a TGFBI R124H mutation. Three of the 11 family members tested positive for the same R124H mutation as the proband.ConclusionThe lesson learned from this case is that the genetic screening of TGFBI mutations must be incorporated into the pre-operative screening procedures to prevent exacerbation and recurrence, which eventually could lead to the need for a corneal transplant.
LASIK 术后角膜营养不良加重,无症状,几乎完全与 TGFBI 基因突变有关,突变位于外显子 4 的 124 密码子和外显子 12 的 555 密码子。我们旨在证明,屈光手术候选者术前应进行 TGFBI 突变的基因筛查。
在这项研究中,我们回顾了先证者 LASIK 术后裂隙灯和活体共聚焦显微镜图像和基因检测结果,并对 11 名家族其他成员进行了基因检测,以调查携带突变的无症状成员中角膜营养不良的外显率。
先证者表现出颗粒状角膜营养不良 2 型(GCD2)的 LASIK 术后加重,鉴定为 TGFBI R124H 突变。11 名家族成员中有 3 名检测到与先证者相同的 R124H 突变。
从这个病例中得到的教训是,必须将 TGFBI 突变的基因筛查纳入术前筛查程序,以预防加重和复发,最终可能需要进行角膜移植。